Skip to main content

Table 1 IC50 (μM) for pancreas cancer cell lines treated with sigma-2 ligands for 18 hours.

From: The novel sigma-2 receptor ligand SW43 stabilizes pancreas cancer progression in combination with gemcitabine

Cell Line SV119 SW43 SRM
Panc02 50 ± 9 21 ± 0 11 ± 2
MiaPaCa2 58 ± 8 29 ± 6 17 ± 1
Panc1 64 ± 10 35 ± 3 19 ± 2
Bxpc3 84 ± 17 38 ± 2 19 ± 3
Cfpac 76 ± 14 49 ± 4 16 ± 1
Aspc1 106 ± 7 56 ± 1 36 ± 8
  1. (Mean ± SEM), n ≥ 3